CIK 0001811063
- Non-accelerated filer
- Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850862255
- Phone
- +1 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF MEDICAL OFFICER sold 20,000 shares at $2.50 ($50,024)
- 4 Open-market buy PRESIDENT AND CEO bought 500,000 shares at an average $1.64 ($820,220)
- 4 Open-market buy Director bought 100,000 shares at an average $1.67 ($166,985)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO, ANHEART THERAPEUTICS LTD. sold 56,361 shares at $2.89 ($162,883)
- 4 Open-market buy Director bought 100,000 shares at an average $2.20 ($220,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 10 · 184 filings